Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD

Singh, Dave; Nicolini, Gabriele; Bindi, Eddi; Corradi, Massimo; Guastalla, Daniele; Kampschulte, Jorg; Pierzchala, Wladyslaw; SAYINER, ABDULLAH; Szilasi, Maria; Terzano, Claudio; Vestbo, Jorgen

doi:10.1186/1471-2466-14-43

Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD

Atıf İçin Kopyala

Singh D., Nicolini G., Bindi E., Corradi M., Guastalla D., Kampschulte J., et al.

BMC PULMONARY MEDICINE, cilt.14, 2014 (SCI İndekslerine Giren Dergi)

Cilt numarası: 14
Basım Tarihi: 2014
Doi Numarası: 10.1186/1471-2466-14-43
Dergi Adı: BMC PULMONARY MEDICINE

Özet

Background: The study evaluated the efficacy of beclomethasone dipropionate/formoterol fumarate (BDP/FF) extrafine combination versus fluticasone propionate/salmeterol (FP/S) combination in COPD patients.